In This Week’s Update:
- Center for Community Health and Prevention Receives Award
- Lynne Maquat Awarded the Warren Alpert Foundation Prize
- URMC, RRH Test New COVID Vaccine Against South African Variant
- Get Real-World Clinical Data from the TriNetX Research Network
- NIH Office of Research on Women’s Health Symposium
- Forum: Health Literacy and the Informed Consent Process
- UR CTSI's Scott Steele Named to ACTS Board of Directors
- National COVID Cohort Collaborative (NC3) Domain Teams
- Propose a New CTSA Working Group By June 1
- 2021 Furth Fund Recipients
- Funding Opportunities
- Apply for Environmental Health Science Pilot Funds
- Impact of COVID on Risk for Abuse Among Vulnerable Children
- Patient-Centered Outcomes Research Institute Funding
|
|
Center for Community Health and Prevention Receives Award
The Center for Community Health and Prevention (CCHP) has been recognized by the New York State Public Health Association for its contributions to public health and for being a leader in our community. CCHP Director, Nancy Bennett, M.D., who is also co-director of the UR CTSI, accepted the Outstanding Leadership in Public Health in New York State Award on behalf of the Center at an awards ceremonty on April 29. Read the full article which has a link to view the ceremony.
|
|
Lynne Maquat Awarded the Warren Alpert Foundation Prize
Lynne Maquat, Ph.D., professor of Biochemistry and Biophysics at URMC, was awarded the Warren Alpert Foundation Prize for her pivotal discoveries in the field of RNA biology last week. She shares the prize with fellow RNA biologist Joan Steitz, Ph.D., Sterling Professor of Molecular Biophysics and Biochemistry at the Yale School of Medicine. Decades of research by Maquat and Steitz on how RNAs work and how they are involved in human disease helped set the stage for the rapid development of the mRNA COVID vaccines. The UR CTSI is proud to have supported some of Maquat's RNA biology research in the past.
|
|
URMC, RRH Test New COVID Vaccine Against South African Variant
URMC and Rochester Regional Health are at the forefront of COVID research again as they join national studies to test a vaccine that targets the new, more contagious South African variant of the coronavirus. The new vaccine, produced by Pfizer and BioNTech, is a slight twist on the companies’ highly effective existing COVID vaccine.
|
|
Get Real-World Clinical Data from the TriNetX Research Network
Are you interested in real-world clinical data? TriNetX, a user-friendly cohort discovery tool offered through the UR CTSI, just added a new feature that can get you what you need. Users can now get de-identified datasets from the TriNetX Research Network, which queries 60 million patients across 40 health care institutions. With the click of a button, a simple data request process will begin. Learn more on the UR CTSI’s TriNetX webpage.
|
|
NIH Office of Research on Women’s Health Symposium
The NIH Office of Research on Women’s Health (ORWH) is hosting the virtual 5th Annual Vivian W. Pinn Symposium. This year’s meeting, Integrating Sex and Gender into Biomedical Research as a Path for Better Science and Innovation, will illustrate the scientific, societal and economic opportunities for integrating sex and gender considerations into biomedical research. The symposium will feature an array of world-renowned speakers and panelists, including a special fireside chat featuring NIAID Director Anthony S. Fauci, M.D., and the first ORWH Director, Vivian W. Pinn, M.D.
Date: Tuesday, May 11 – Wednesday, May 12
Time: 9:00 am – 6:30 pm
|
|
Health Literacy and the Informed Consent Process
Mark Nickels, M.D., professor of Psychiatry at URMC, will present Health Literacy and the Informed Consent Process at the next Human Research Protection Program Educational Forum. Through this talk, Nickels aims to enhance subject/patient health literacy and understanding using plain language and teach-back methods in the informed consent process.
Date: Thursday, May 13
Time: 12:00 – 1:00 pm
|
|
UR CTSI's Scott Steele Named to ACTS Board of Directors
Scott Steele, Ph.D., director of UR CTSI Regulatory Science Programs, has been named to the Association for Clinical and Translational Science (ACTS) Board of Directors for a second term, 2021-2022. The role of the board is to govern, establish policy and make strategic decisions about the future of the organization. They'll continue to advocate for clinical and translational research funding, as well as diversity and inclusion efforts, and identify new research trends and developments where ACTS can have an impact.
|
|
National COVID Cohort Collaborative (NC3) Domain Teams
National COVID Cohort Collaborative (NC3) Domain Teams enable researchers with shared interests to collaborate more efficiently and analyze data within the N3C Data Enclave, a secure platform housing harmonized COVID clinical data. These teams provide an opportunity to collect pilot data for grant submissions, train algorithms on larger datasets, inform clinical trial design, learn how to use tools for large-scale COVID data and validate results. Learn how University of Rochester researchers can benefit from the N3C and the broader Center for Data to Health.
|
|
Propose a New CTSA Working Group By June 1
University of Rochester researchers who are passionate about developing solutions to specific clinical and translational science issues can submit a proposal to start a working group through the Clinical and Translational Science Awards (CTSA) Program. Working groups must propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high-priority areas. Projects may result in outputs such as consensus papers, white papers, publications, workshops, symposiums, meetings or a conference. Submit proposals by Tuesday, June 1.
|
|
2021 Furth Fund Recipients
Andrea Pickel, Ph.D., assistant professor of Mechanical Engineering in the Hajim School of Engineering and Applied Sciences, and Benjamin Suárez-Jiménez, Ph.D., assistant professor of Neuroscience at URMC, are this year's Furth Fund recipients. The Furth Fund provides early-career scientists with $12,500 in research funds to foster the development of promising scientists in the natural and biological sciences.
|
|
Funding Opportunities
In addition to the new funding opportunities shown below, the UR CTSI Funding Calendar lists many other grant deadlines which can be searched by funding institution, topic or date. You can also find the calendar on the UR CTSI Funding page.
Apply for Environmental Health Science Pilot Funding
The Environmental Health Sciences Center is seeking proposals for pilot projects to investigate environmental agents as modulators of human disease and dysfunction, particularly exploring the developmental origins of disease at any subsequent stage of the life cycle as well as interventions for mitigating such effects. Applicants may request a maximum of $30,000 for the duration of one year and must hold a tenure-track faculty position. Interested applicants are encouraged to contact Martha Susiarjo or Pat Noonan-Sullivan for more information or relevance of their proposal. Apply by Tuesday, June 1.
Impact of COVID on Risk for Abuse Among Vulnerable Children
Treating injured and traumatized children and implementing preventive interventions has been difficult during the pandemic and children are at greater risk of injury, morbidity and mortality due to social isolation and economic stress. The Eunice Kennedy Shriver National Institute of Child Health and Human Development is seeking revision or new research study applications to investigate treatment and care in diverse (e.g. primary, emergency and acute care) settings to identify effective ways of screening, diagnosing and assessing trends in abuse and abuse-related injuries in this current context. Apply by Saturday, June 5.
Patient-Centered Outcomes Research Institute Funding
The Patient-Center Outcomes Research Institute (PCORI) has released several funding announcements covering topics such as postpartum maternal outcomes, intellectual and developmental disabilities, urinary incontinence, shared decision making and implementing PCORI-funded research results. Letters of Intent are due in early or late June, depending on the funding announcement.
|
|
|
|
|
